|
|
|
|
|
02.06.26 - 22:36
|
Alvotech to present at upcoming investor conferences in June (GlobeNewswire EN)
|
|
|
REYKJAVIK, ICELAND (June 2, 2026) — Alvotech (NASDAQ: ALVO; ALVO-SDB) (the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that Robert Wessman, Alvotech's Founder and Executive Chairman, and Dr. Balaji V. Prasad, Chief Strategy Officer, will participate in the upcoming investor conferences in June as follows:...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
20.05.26 - 02:30
|
Auna S.A. (AUNA) Lags Q1 Earnings Estimates (Zacks)
|
|
|
Auna S.A. (AUNA) delivered earnings and revenue surprises of -72.97% and +2.42%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?...
|
|
|
19.05.26 - 23:54
|
Auna Announces 1Q26 Financial Results (Business Wire)
|
|
|
Strong top-line growth and cash flow performance;
Consolidated Adjusted EBITDA impacted by revenue adjustments;
Mexico volumes and revenues growing rapidly, with Segment Adjusted EBITDA increasing 19% QoQLUXEMBOURG--(BUSINESS WIRE)--Auna (NYSE: AUNA) (“Auna” or the “Company”), a leading healthcare platform in Latin America with operations in Mexico, Peru, and Colombia, announced today financial results for the first quarter ended March 31, 2026 (“first quarter 2026” or “1Q26”). Financial results are expressed in Peruvian Soles (“S/” or “PEN” or “Soles”) and are presented in accordance with International Financial Reporting Standards (“IFRS”), unless otherwise noted.
1Q'26 Consolidated Highlights
Revenue increased 10% FXN, or 13% YoY on a reported basis, to S/1,178 million
Mexico Revenue increased 15% YoY on a reported basis, to S/ 279 million
Adjusted EBITDA was S/217 million, a decrease of 2% YoY
Adjusted EBITDA Margin of 18.4%, down 2.9 p.p. YoY from 21.4% in 1Q25
Operat...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
